Clinical Pharmacology & Therapeutics · 1973 · 29 citations · 0 references
PharmacyPharmacokineticsPharmacologyBioavailabilityNoncompartmental AnalysisPharmacodynamicsDrug DispositionPotassium HomeostasisPotassium AdministrationPotassium Concentration MeasurementUrinary OutputUrinary Potassium Excretion
The bioavailability of potassium (K) from orally administered 10 per cent potassium chloride (KCI) solution has been compared with that from a slow‐release KCl tablet (Slow‐K) in 10 normal subiects under metabolic balance conditions. After a single 40 mEq. KCl dose, urinary K increased sooner and to greater peak levels after the solution was administered. In both cases greater amounts of K appeared in the urine when administered in the fasting than in the postprandial state. In 4 days of administration there was no difference in the net increment in urine K produced by equivalent doses of either preparation. No significant toxicity was experienced with either preparation. The unpleasant taste of the KCI solution was noted by each subject.